Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
K-Fast Holding B | KFASTB | Mar 27, 2024 | 21.30 | -0.75 |
K2A Knaust & Andersson Fastigheter B | K2AB | Mar 27, 2024 | 8.42 | +0.12 |
K2A Knaust & Andersson Fastigheter Pref | K2APREF | Mar 27, 2024 | 199.50 | 0.00 |
KABE Group B | KABEB | Mar 27, 2024 | 306.00 | -0.81 |
Kakel Max | KAKEL | Mar 27, 2024 | 9.65 | 0.00 |
Kallebäck Property Invest | KAPIAB | Mar 27, 2024 | 186.00 | -0.53 |
Kambi Group | KAMBI | Mar 27, 2024 | 91.85 | -0.16 |
Kancera | KAN | Mar 27, 2024 | 1.71 | -13.70 |
Karnell Group AB (publ) | KARNELB | 0.00 | 0.00 | |
Karnov Group | KAR | Mar 27, 2024 | 65.10 | -1.66 |
Karolinska Development B | KDEV | Mar 27, 2024 | 1.52 | -0.91 |
Katalysen Ventures AB | KAV | Mar 27, 2024 | 15.20 | -0.65 |
KebNi B | KEBNIB | Mar 27, 2024 | 1.44 | -3.62 |
Kentima Holding B | KENH | Mar 27, 2024 | 1.74 | -2.79 |
Kiliaro | KILI | Mar 27, 2024 | 0.83 | -4.60 |
Kindred Group SDB | KINDSDB | Mar 27, 2024 | 124.40 | +0.28 |
Kinnevik A | KINVA | Mar 27, 2024 | 119.80 | +1.18 |
Kinnevik B | KINVB | Mar 27, 2024 | 118.95 | +0.98 |
Kjell Group | KJELL | Mar 27, 2024 | 19.45 | +0.78 |
KlaraBo | KLARAB | Mar 27, 2024 | 20.50 | +5.89 |
Klaria Pharma Holding | KLAR | Mar 27, 2024 | 0.33 | +6.45 |
Klimator | KLIMAT | Mar 27, 2024 | 1.50 | -3.22 |
Knowit | KNOW | Mar 27, 2024 | 164.60 | +2.88 |
Kollect on Demand Holding | KOLL | Mar 27, 2024 | 1.20 | +2.13 |
Kontigo Care | KONT | Mar 27, 2024 | 2.11 | -5.80 |
Kopparbergs B | KOBRB | Mar 27, 2024 | 116.00 | +1.31 |
Kopy Goldfields | KOPY | Mar 27, 2024 | 0.30 | -6.54 |
Krona Public Real Estate | KRONA | Mar 27, 2024 | 38.20 | 0.00 |
Kvix | KVIX | Mar 27, 2024 | 0.32 | 0.00 |
Lagercrantz Group B | LAGRB | Mar 27, 2024 | 163.90 | +0.86 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.